Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.9% After Analyst Downgrade
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) were down 8.9% during trading on Monday after Bank of America lowered their price target on the stock from $30.00 to $28.00. Bank of America currently has a buy rating on the stock. Denali Therapeutics traded as low as $15.16 and last traded at $15.20. […]
Shares of Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) were down 8.9% during trading on Monday after Bank of America lowered their price target on the stock from $30.00 to $28.00. Bank of America currently has a buy rating on the stock. Denali Therapeutics traded as low as $15.16 and last traded at $15.20. […]
